A detailed history of Dowling & Yahnke LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 204,469 shares of PFE stock, worth $5.47 Million. This represents 4.17% of its overall portfolio holdings.

Number of Shares
204,469
Previous 203,946 0.26%
Holding current value
$5.47 Million
Previous $10.7 Million 16.32%
% of portfolio
4.17%
Previous 0.5%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $22,886 - $27,938
523 Added 0.26%
204,469 $8.95 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $69,562 - $82,479
-1,495 Reduced 0.73%
203,946 $10.7 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $424,194 - $525,629
-9,272 Reduced 4.32%
205,441 $10.6 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $114,910 - $170,336
-2,781 Reduced 1.28%
214,713 $12.7 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $45,294 - $58,184
1,154 Added 0.53%
217,494 $9.35 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $94,191 - $106,703
2,623 Added 1.23%
216,340 $8.47 Million
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $115,440 - $130,193
-3,447 Reduced 1.59%
213,717 $7.74 Million
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $655,945 - $834,090
19,598 Added 9.92%
217,164 $7.99 Million
Q3 2020

Oct 19, 2020

BUY
$31.75 - $37.25 $136,715 - $160,398
4,306 Added 2.23%
197,566 $7.25 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $202,797 - $246,023
6,733 Added 3.61%
193,260 $6.32 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $395,719 - $565,396
-14,640 Reduced 7.28%
186,527 $6.09 Million
Q4 2019

Jan 27, 2020

SELL
$32.92 - $37.36 $315,439 - $357,983
-9,582 Reduced 4.55%
201,167 $7.88 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $2,729 - $3,538
-84 Reduced 0.04%
210,749 $7.57 Million
Q2 2019

Jul 22, 2019

BUY
$36.98 - $41.52 $109,534 - $122,982
2,962 Added 1.42%
210,833 $9.13 Million
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $261,000 - $286,752
6,960 Added 3.46%
207,871 $8.83 Million
Q4 2018

Jan 24, 2019

BUY
$38.47 - $43.86 $124,488 - $141,930
3,236 Added 1.64%
200,911 $9.29 Million
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $108,373 - $131,450
-3,144 Reduced 1.57%
197,675 $8.71 Million
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $81,658 - $87,056
-2,476 Reduced 1.22%
200,819 $7.29 Million
Q1 2018

May 01, 2018

SELL
$31.91 - $37.02 $106,994 - $124,128
-3,353 Reduced 1.62%
203,295 $7.22 Million
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $32,162 - $34,125
-967 Reduced 0.47%
206,648 $7.49 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $6.44 Million - $7.09 Million
207,615
207,615 $7.41 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.